Antipsychotics (General) Flashcards
Psychosis
Abnormal condition of the mind
Schizophrenia (What is it?)
Psychiatric Illness (Disorder)
Schizophrenia (Affects Who?)
Affects young people
Strong hereditary factor
Schizophrenia (Positive Symptoms)
Excess/Distortion of normal behaviour:
- Delusions
- Hallucinations
- Thought Disorder: Wild thoughts, delusions
Schizophrenia (Negative Symptoms)
Absence/Loss of normal behaviour
- Withdrawal from social contacts
- Flattening of emotional response
- Inability to enjoy pleasure (Anhedonia)
Schizophrenia (Other Symptoms)
Deficits in cognitive function
- Attention
- Memory
Schizophrenia (Positive Symptoms)
- Neurotransmitters Involved
Under-activity of glutamate
- Receptor hypofunction (Glu/NMDA Receptor)
Dopamine Dysregulation
- Too much/little in some areas
Schizophrenia (Positive Symptoms)
- Mechanism
Overactivation of D2 in mesolimbic pathways
NMDA Receptor Hypofunction
- Not enough activation of GABAergic Neurons –> Not enough inhibition of dopaminergic neurons
–> Too much synthesis and release of dopamine
Schizophrenia (Negative Symptoms)
- Mechanism
Decreased activity of D1 dopamine receptors in mesocortical pathway
–> Not enough NMDA receptor activity
–> Too little activation of dopaminergic neurons
What pathways are responsible positive/negative symptoms
- Mesolimbic
- Mesocortical
Mesolimbic = Positive Symptoms
Mesocortical = Negative Symptoms
Schizophrenia (Cognitive Symptoms)
- Mechanism
NMDA Receptor Hypofunction
–> Affects GABAergic Interneurons altering cortical processing and causing cognitive impairment
Schizophrenia (Treating Positive vs Negative Symptoms)
Treatments work better on Positive Symptoms
–> They target D2 Receptors
Antipsychotics (Mechanism of Treatment)
Antagonism of D2 Receptors
- Also block many other receptors
–> Can cause good/bad side effects
First Generation Antipsychotics vs
Second Generation Antipsychotics
1st Gen:
- D1 Selectivity = D2 Selectivity
- Higher Extrapyramidal Disturbances
- Less Effective Against Negative Symptoms
2nd Gen:
- D2 Selectivity > D1 Selectivity
- Lower Extrapyramidal Disturbances
- Effective Against Negative Symptoms
–> 5-HT2A Antagonism
Antipsychotics
- Extrapyramidal Side Effects
Motor Disturbances
- Blocks D2 Receptors in Nigrostriatal Pathway
Parkinson’s Disease (Dystonia)
- Involuntary movements
Irreversible Dyskinesia
- Involuntary movement of face, limbs, tongue